TCV Trust & Wealth Management’s Celgene Corp CELG Stock Holding History

TCV Trust & Wealth Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,450	Closed	-$218K	–	215
2018 Q1	$218K	Buy	+2,450	New	+$235K	0.03%	190
2017 Q4	–	Sell	-2,630	Closed	-$384K	–	208
2017 Q3	$384K	Buy	2,630 +700	+36%	+$95.3K	0.06%	142
2017 Q2	$250K	Buy	1,930 +140	+8%	+$17.2K	0.04%	168
2017 Q1	$223K	Hold	1,790	–	–	0.03%	179
2016 Q4	$207K	Buy	+1,790	New	+$199K	0.03%	174
2016 Q1	–	Sell	-1,790	Closed	-$215K	–	169
2015 Q4	$215K	Buy	+1,790	New	+$207K	0.04%	155
2015 Q3	–	Sell	-1,790	Closed	-$207K	–	180
2015 Q2	$207K	Hold	1,790	–	–	0.03%	169
2015 Q1	$207K	Buy	+1,790	New	+$214K	0.03%	176

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCV Trust & Wealth Management's CELG Position: Q2 2018 in Review

TCV Trust & Wealth Management sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 2,450 shares — an estimated $218K sold.

TCV Trust & Wealth Management first reported a position in CELG in Q1 2015 and held it in 8 quarters. The position peaked at $384K in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

TCV Trust & Wealth Management reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
TCV Trust & Wealth Management sold 2,450 Celgene Corp shares in Q2 2018, an estimated $218K.
TCV Trust & Wealth Management first reported a position in Celgene Corp in Q1 2015 and held it in 8 quarters.
TCV Trust & Wealth Management's Celgene Corp position peaked at $384K in Q3 2017.
1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on TCV Trust & Wealth Management's 13F filing for Q2 2018, filed 7 Aug 2018.